Published • loading... • Updated
GLP-1 drugs may have a beneficial effect across many types of cancer
More than two dozen studies found GLP-1 users had lower cancer risk, slower spread and better survival, though researchers said observational data cannot prove cause.
9 Articles
9 Articles
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
Studies presented at ASCO suggest GLP-1 drugs, including Ozempic, are associated with lower cancer risk, reduced metastasis and improved survival across multiple tumour types, though trials are needed.
·Singapore, Singapore
Read Full Article
GLP-1 drugs may have a beneficial effect across many types of cancer
·New York, United States
Read Full Article
GLP-1 drugs, known worldwide for their effectiveness in controlling diabetes and promoting weight loss, are awakening a growing interest within the scientific community for a possible additional benefit: reducing cancer risk and a better evolution of the disease in oncological patients. Over the past few days, researchers presented more than two dozen studies at the annual meeting of the American Society of Clinical Oncology (ASCO), held in Chic…
Coverage Details
Total News Sources9
Leaning Left1Leaning Right1Center5Last UpdatedBias Distribution72% Center
Bias Distribution
- 72% of the sources are Center
72% Center
14%
C 72%
14%
Factuality
To view factuality data please Upgrade to Premium
